Applied DNA Sciences (APDN) Misses Q1 EPS by 36c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Applied DNA First Quarter Fiscal 2022 Financial Results Feature Record Quarterly Revenues
February 10, 2022 4:05 PM EST- Revenues of $4.2 Million Increased 158% Year-over-Year and 37% Sequentially -
- Momentum Continues into FQ2 with January Revenues of Approximately $2.0 Million -
- Company to Hold Conference Call and Webcast Today, Thursday, February 10, 2022, at 4:30 PM ET -
STONY BROOK, N.Y.--(BUSINESS WIRE)-- Applied DNA Sciences, Inc. (NASDAQ:... More
